These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9154276)

  • 1. Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids.
    Resul B; Stjernschantz J; Selén G; Bito L
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S47-52. PubMed ID: 9154276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of 17-phenyl-18,19,20-trinorprostaglandin F2 alpha isopropyl ester: potential antiglaucoma agents.
    Liljebris C; Selén G; Resul B; Stjernschantz J; Hacksell U
    J Med Chem; 1995 Jan; 38(2):289-304. PubMed ID: 7830272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
    Stjernschantz J; Selén G; Astin M; Resul B
    Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.
    Woodward DF; Burke JA; Williams LS; Palmer BP; Wheeler LA; Woldemussie E; Ruiz G; Chen J
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1838-42. PubMed ID: 2759797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.
    Resul B; Stjernschantz J; No K; Liljebris C; Selén G; Astin M; Karlsson M; Bito LZ
    J Med Chem; 1993 Jan; 36(2):243-8. PubMed ID: 8423596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
    Hellberg MR; Conrow RE; Sharif NA; McLaughlin MA; Bishop JE; Crider JY; Dean WD; DeWolf KA; Pierce DR; Sallee VL; Selliah RD; Severns BS; Sproull SJ; Williams GW; Zinke PW; Klimko PG
    Bioorg Med Chem; 2002 Jun; 10(6):2031-49. PubMed ID: 11937363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
    Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
    Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the ocular hypotensive effects of prostaglandin F2 alpha ester prodrugs and receptor selective prostaglandin analogs.
    Woodward DF; Chan MF; Burke JA; Cheng-Bennett A; Chen G; Fairbairn CE; Gac T; Garst ME; Gluchowski C; Kaplan LJ
    J Ocul Pharmacol; 1994; 10(1):177-93. PubMed ID: 8207325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.
    Nakajima T; Matsugi T; Goto W; Kageyama M; Mori N; Matsumura Y; Hara H
    Biol Pharm Bull; 2003 Dec; 26(12):1691-5. PubMed ID: 14646172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
    Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
    J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical studies with prostaglandins and their analogues.
    Camras CB; Alm A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.
    Cheng-Bennett A; Chan MF; Chen G; Gac T; Garst ME; Gluchowski C; Kaplan LJ; Protzman CE; Roof MB; Sachs G
    Br J Ophthalmol; 1994 Jul; 78(7):560-7. PubMed ID: 7918269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.
    Feng Z; Hellberg MR; Sharif NA; McLaughlin MA; Williams GW; Scott D; Wallace T
    Bioorg Med Chem; 2009 Jan; 17(2):576-84. PubMed ID: 19101156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].
    Ueno R; Yoshida S; Deguchi T; Kato I; Oda T; Hayashi Y; Kuno S
    Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):462-8. PubMed ID: 1621584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro.
    Basu S; Sjöquist B; Stjernschantz J; Resul B
    Prostaglandins Leukot Essent Fatty Acids; 1994 Apr; 50(4):161-8. PubMed ID: 8022849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.
    Bito LZ; Miranda OC; Tendler MR; Resul B
    Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes.
    Gum GG; Kingsbury S; Whitley RD; Garcia A; Gelatt KN
    J Ocul Pharmacol; 1991; 7(2):107-16. PubMed ID: 1919268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.